SPG7 Antikörper
Kurzübersicht für SPG7 Antikörper (ABIN5891511)
Target
Alle SPG7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Affinity purified
-
Isotyp
- IgG
-
-
anti-Spastic Paraplegia 7 (SPG7) (AA 300-573) antibody
SPG7 Reaktivität: Human, Maus WB, IF, FACS Wirt: Maus Monoclonal 1C12 unconjugated
anti-Spastic Paraplegia 7 (SPG7) (AA 300-573) antibodySPG7 Reaktivität: Human WB, IF, FACS Wirt: Maus Monoclonal 3H10 unconjugated
anti-Spastic Paraplegia 7 (SPG7) antibodySPG7 Reaktivität: Human WB, FACS Wirt: Maus Monoclonal 25GB5505 unconjugated
anti-Spastic Paraplegia 7 (SPG7) (AA 115-141) antibodySPG7 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB23654 unconjugated
anti-Spastic Paraplegia 7 (SPG7) (AA 1-250) antibodySPG7 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Spastic Paraplegia 7 (SPG7) (AA 1-795) antibodySPG7 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Spastic Paraplegia 7 (SPG7) (AA 1-795) antibodySPG7 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Spastic Paraplegia 7 (SPG7) (AA 114-141), (Middle Region) antibodySPG7 Reaktivität: Human WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- > 1 mg/mL
-
Buffer
- PBS, pH 7.3, 0.02 % sodium azide, 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
-
-
- SPG7 (Spastic Paraplegia 7 (SPG7))
-
Andere Bezeichnung
- SPG7
-
Molekulargewicht
-
Calculated MW: 53 kDa/88 kDa
Observed MW: 88 kDa -
Gen-ID
- 6687
-
UniProt
- Q9UQ90
Target
-
